NDC11 59148000813
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 59148-0008-13 | 59148-0008 |
| 59148-008-13 | 59148-008 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ABILIFY | ARIPIPRAZOLE | Otsuka America Pharmaceutical, Inc. | c040bd1d-45b7-49f2-93ea-aed7220b30ac | 2025-01-29 | Boxed warning, Warnings, Adverse reactions | 59148-008-13 59148-008 59148000813 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.